AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06110065 — intervention group
Intervention type: DRUG
Intervention: CT-guided Pudendal Nerve Cryoneurolysis
Description: CT-guided bilateral pudendal nerve cryoneurolysis involves using advanced imaging technology to precisely target and freeze the pudendal nerves, which are responsible for transmitting pain signals.
Study NCT06110065 — intervention group
Intervention type: DRUG
Intervention: Percutaneous image-guided cryoneurolysis
Description: Percutaneous image-guided cryoneurolysis focuses on using extremely cold temperatures to alleviate pain originating from the pudendal nerves. This method has demonstrated extended pain relief compared to alternatives like injections or catheters. Additionally, it presents a lower risk of certain complications.
Study NCT06195462 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Laying on of hands with intention health (LHHI)
Description: The participants will receive systemic acupuncture. The no healers will move their hands in a longitudinal direction, starting at the top of the patient's head, slowly lowering their hands along the body, 5 times and asked to send thoughts of health and healing to the participant. Then, they will place their hands on the patient's head, distance about 10 to 15 cm, during 5 minutes. Weekly sessions.
Study NCT06195462 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laying on of hands by spiritist passe
Description: The participants will receive systemic acupuncture. The healers will prepare before the start with prayer for connection with Good Spirits and will move their hands in a longitudinal direction, starting at the top of the patient's head, slowly lowering their hands along the body, 5 times and asked to send thoughts of health and healing to the participant. Then, they will place their hands on the patient's head, distance about 10 to 15 cm, during 5 minutes. Weekly sessions.
Study NCT06195462 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: The participants will receive systemic acupuncture and they not receive the laying on of hands.
Study NCT05245591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pentosan Polysulfate Sodium 100 MG Oral Capsule
Description: Pentosan Polysulfate Sodium 100 mg three times daily (tid) for 0-8 weeks Pentosan Polysulfate Sodium 100 mg twice daily (bid) for 9-16 weeks
Study NCT05245591 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 100 mg three times daily (tid) for 0-8 weeks Placebo 100 mg twice daily (bid) for 9-16 weeks
Study NCT06294197 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Exercises
Description: In the intervention types, women are given training on pelvic floor exercises, that they can perform in the form of home exercises for 12 weeks. Before starting pelvic floor exercises therapy, a physiotherapist who specializes in pelvic floor compatibility will provide information about the location of the pelvic floor muscles through anatomical models and their effect on healthy, vaginal and sexual function. The effects of pelvic floor exercises on this system will be explained on an individual basis, and normal palpation is required to demonstrate their correct execution of contraction of the pelvic floor muscles. Participants will be taught how to contract and contract different muscles, such as the abdominal muscles, hip muscles, and gluteal muscles, or how to avoid pelvic tilt during contraction, and how to perform both rapid and sustained contractions.
Study NCT04673045 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Electrical stimulation
Description: The intensity of stimulation will be set within the subject's tolerance level. The amplitude was adjusted to produce muscle contraction without affecting the patient's comfort. The cathode electrode will be placed over the common peroneal nerve as it passes over the head of the fibula and the anode will be placed on mid-muscle belly on one third of the line between fibular head and medial malleolus on paretic limb.
Study NCT04673045 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Electrical Stimulation
Description: For sham group, the current intensity will gradually decreased after few seconds to 0. Therefore, the participant will experience a passage of current on the muscle at the beginning but received no current for the rest of the stimulation period. The participants will be informed that the stimulation below the sensory level.
Study NCT06074627 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Energy Active Study Product 1.2 Usage
Description: Participants will use their Radicle Energy Active Study Product 1.2 as directed for a period of 6 weeks.
Study NCT06074627 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Energy Active Study Product 1.3 Usage
Description: Participants will use their Radicle Energy Active Study Product 1.3 as directed for a period of 6 weeks.
Study NCT04843358 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Disclosure
Description: The trial member will deliver instructions For the next three days, I want you to write about your experience with cancer. In your writing, I want you to really let go and explore your very deepest emotions and thoughts. It is critical that you delve deeply. Ideally, I would like you to write about those parts of the experience you found hard to share with others. Perhaps this will provide an opportunity to really examine those thoughts and emotions. You might tie your personal experiences to other parts of your life. How is it related to your family life, relationship with your spouse, your children, your sexuality, daily activities, hobbies, your past, your childhood, your work? These are just some examples.
Study NCT04843358 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-Emotional Writing
Description: The trial member will deliver instructions were as follows. For the next three days, I want you to write about how you use your time. We are interested in everything you do during the course of a day. In your writing I want you to be completely objective. We are not interested in your emotions or opinions. Feel free to be as detailed as possible
Study NCT05005767 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: scaling and root planing
Description: will receive scaling and root planing only
Study NCT05005767 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planing
Description: will receive scaling and root planing only
Study NCT05005767 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Frankincense extract gel natural herbal product
Description: will receive Scaling and root planing then. Subgingival application of Frankincense extract gel
Study NCT06183983 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Extended MRI
Description: The MRI-protocol before radiotherapy is extended with 20 minutes.
Study NCT06305260 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lumbar Ultrasound
Description: Investigators will utilize our ultrasound machine to complete a pre-procedural lumbar ultrasound prior to epidural placement.
Study NCT04789057 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 Mg Oral Tablet
Description: p.o., once daily
Study NCT04789057 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: p.o., once daily
Study NCT04347655 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: handgrip test
Description: The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes.
Study NCT04347655 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: handgrip test
Description: The patient will be supine for at least 5 minutes to collect baseline data before being handed a dynamometer device. The subject will then be asked to squeeze the dynamometer with maximum force for a minimum of 2 minutes while only engaging their forearm and remaining relaxed in the rest of their body. The subject will then release the dynamometer and remain supine, in recovery, for a minimum of 5 minutes.
Study NCT05208580 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual education
Description: Participants undergo virtual education activities on an on-line platform 10-14 days before the surgery
Study NCT05208580 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contact education
Description: Participants attend live educational classes 10-14 days before the surgery
Study NCT06336512 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ELISA
Description: Estimation of Zonulin by ELISA from the Blood samples which were obtained at time of pregnancy .
Study NCT06189430 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Yoga practice was standardized throughout the study to avoid the risk of intervention variability. The basic structure of each yoga session is meditation, breathing exercises (pranayama), and after a warm-up, yoga practice includes asanas (postures) for strength, balance and mobility, and finally ends with relaxation. The yoga intervention we recommend was created within the framework of the asanas that the elderly can do in the literature and by taking the expert opinion of a sports physician.
Study NCT06189430 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard exercise
Description: It is a type of exercise similar in intensity to vinyasa yoga. (50-70% MHR: maximum pulse rate)
Study NCT06107049 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: BLa80
Description: During the experiment, the subjects took a packet of probiotics every day, and the sleep condition, anxiety level and memory level of the subjects were evaluated by questionnaires and ability tests. The questionnaire included PSQI Pittsburgh Sleep Quality Index scale, ISI Insomnia Severity Index Scale and GSRS gastrointestinal symptom Score scale.
Study NCT06107049 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BLa80
Description: During the experiment, the subjects took a packet of probiotics every day, and the sleep condition, anxiety level and memory level of the subjects were evaluated by questionnaires and ability tests. The questionnaire included PSQI Pittsburgh Sleep Quality Index scale, ISI Insomnia Severity Index Scale and GSRS gastrointestinal symptom Score scale.
Study NCT04417569 — intervention group
Intervention type: DRUG
Intervention: hCG
Description: human chorionic gonadotropin
Study NCT04417569 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: Endometrial thickness monitoring
Study NCT04417569 — intervention group
Intervention type: OTHER
Intervention: Blood test
Description: Progesterone, Luteinizing Hormone, Estradiol
Study NCT06395922 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blockbuster LMA
Description: The LMA was inserted using the recommended technique, with the patient's head in the sniffing position. The appropriate size was selected based on body weight (size 3 for 30-50 kg, size 4 for 50-70 kg)
Study NCT06395922 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Baska Mask
Description: The BM was inserted by opening the mouth, avoiding the tongue, and negotiating the palatopharyngeal curve using the hand-tab.
Study NCT05733416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: FDG PET/CT
Description: F-fluorodeoxyglucose positron emission/computed tomography
Study NCT05733416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Usual Care
Description: Cancer screening according to sex, age and risk as per Canadian Task Force on Preventative Health Care
Study NCT06229249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carpal ligament self-myofascial stretching
Description: Carpal ligament self-myofascial stretching is a technique that involves applying pressure and stretching to the carpal ligaments and surrounding myofascial tissues of the wrist and hand. The objective is to release tension, improve flexibility, and alleviate discomfort or pain in the wrist and hand area.
Study NCT06229249 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy
Description: In this technique, ultrasound therapy, nerve gliding exercise, tendon gliding exercise, and wrist splinting were performed.
Study NCT06310083 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy
Description: The study's Participants Were Randomly classified in two groups Interventional Group, applied for Submucosal Resection Turbinoplasty and the controlled group who were applied for Partial Inferior Turbinectomy
Study NCT06310083 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy
Description: The study's Participants Were Randomly classified in two groups Interventional Group, applied for Submucosal Resection Turbinoplasty and the controlled group who were applied for Partial Inferior Turbinectomy
Study NCT06413264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasonography guided Veress needle insertion for creating pneumoperitoneum
Description: A real-time visualisation of the path of the Veress needle entry by the use of high frequency (13-6 MHz) probe ultrasonography.
Study NCT06413264 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Veress needle will be inserted blindly as a closed technique for creating pneumoperitoneum
Description: The Veress needle is inserted blindly and guided by the resistance of tissues and the click sounds of layers of abdominal wall.
Study NCT04976530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DrugSorb-ATR system
Description: Sorbent hemoperfusion system integrated into the cardiopulmonary bypass (CPB) circuit
Study NCT04976530 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: Sham comparator in similar position to the investigative device, but NOT integrated into the cardiopulmonary (CPB) circuit
Study NCT06137911 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JYP0061
Description: JYP0061 orally administered
Study NCT06137911 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo orally administered
Study NCT04792307 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neuromuscular electrical stimulation , no high protein ice cream supplementation
Description: A trained operator applies Neuromuscular electrical stimulation treatment to one leg, for approximately 30 minutes per session, three sessions per week with or without high protein ice cream. Treatment can stimulate the nerve controlling the vastus lateralis muscle in the thigh or the nerve controlling the tibialis anterior muscle in the lower leg, or both. In our study, we will aim to stimulate both nerves and muscle groups, on the basis that the maximal effect with result from the maximal amount of muscle stimulated.Treatment is adjusted to generate a specific force and maintained for up to 5 minutes, followed by a rest period and then repeated three times over the typical 30-minute session. The stimulation can vary according to the frequency (pulses per second, typically 10-50Hz).~Additional protein supplementation: high protein ice cream :a single doses of a high protein supplement after each bout of neuromuscular electrical stimulation,
Study NCT06320353 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPH-075
Description: 100 mg/4 mL (25 mg/mL) concentrate for solution for infusions in a single-dose vial~The required volume (8 ml) of the Drug concentrate solution should be withdrawn from the vials and transferred into an intravenous bag containing 0.9% Sodium Chloride Injection or 5% Dextrose Injection. (The final concentration of the diluted solution should be between 1 mg/mL to 10 mg/mL.)
Study NCT06320353 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Keytruda®
Description: 100 mg/4 mL (25 mg/mL) concentrate for solution for infusions in a single-dose vial~The required volume (8 ml) of the Drug concentrate solution should be withdrawn from the vials and transferred into an intravenous bag containing 0.9% Sodium Chloride Injection or 5% Dextrose Injection. (The final concentration of the diluted solution should be between 1 mg/mL to 10 mg/mL.)
Study NCT06326879 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Questionnaires compilation and sample collection
Study NCT05614583 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MORT-PFPS app
Description: The MORT-PFPS, developed by EverEx, Inc., is designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.
Study NCT05614583 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: treatment as usual (TAU)
Description: In the control group, psychoeducation is delivered and self-exercise is recommended.
Study NCT05000632 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoke Free SafeCare
Description: SFSC is the systematically braided curriculum which combines both SafeCare and STBO programs, but in a new delivery format. To take full advantage of the home delivery mechanism of SafeCare, the content delivery of STBO has been adapted so that original mailings will be delivered in the SafeCare sessions. STBO has been fully braided into the Health and Safety modules. One of these interventions will be delivered first throughout the course of the study. The Smoke Free SafeCare intervention will involve 25 providers receiving training for the SFSC program. They will each recruit 10 mothers and conduct the SFSC program for each family. Overall, 250 families will receive the SFSC intervention.
Study NCT05000632 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard SafeCare
Description: SafeCare is a brief parenting intervention that is highly effective in reducing child maltreatment perpetration and improving behavioral outcomes for CPS-involved parents of young children (0 to 5 years) as the result of child physical abuse or neglect (the two most common forms of substantiated maltreatment). The Standard SafeCare intervention will involve 25 SafeCare providers delivering the SafeCare program as usual. They will each recruit 10 mothers and conduct SafeCare for each family. Overall, 250 families will receive the standard SafeCare.
Study NCT03988998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation with radiotherapy
Description: Radiofrequency ablation with radiotherapy
Study NCT03988998 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency ablation alone
Description: Radiofrequency ablation without radiotherapy
Study NCT05780216 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DMT + harmine
Description: The intervention used in this study is a combination of the two main ingredients of ayahuasca, DMT (N,N-dimethyltryptamine) and harmine in purified form.
Study NCT05780216 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo consists of pharmaceutically inactive ingredients and additional flavors, and is organoleptically hardly distinguishable from the verum.
Study NCT05657756 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Randomize clinical trial using hand dynamometer
Description: Our research article involves 100 patients aged over 18 years old with ASAI\&II divided into two groups, 50 patients will receive atracurium (0.5 mg/kg) and 30 patients receive Rocuronium (0.6 mg/kg). All of our patients will be undergoing elective laparoscopic surgery for cholecystectomy; the patients will randomly select to receive standard anesthesia induction with propofol (2 mg/kg), fentanyl (1-2 mcg/kg), and isoflurane 1.2 Mac, except muscle relaxant. Neuromuscular will monitoring by Train-of-Four (TOF) during surgery.
Study NCT05799469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab
Description: SC
Study NCT05799469 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV infusion
Study NCT05799469 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External Beam Radiotherapy (EBRT)
Description: 45-50.4Gy
Study NCT05799469 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Brachytherapy (BT)
Description: Performed according to clinically required dose
Study NCT04363619 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: OCT and OCTA
Description: Fundoscopy, OCT and OCTA will be performed 4 times in patients
Study NCT04363619 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: OCT and OCTA
Description: Fundoscopy, OCT and OCTA will be performed 4 times in patients
Study NCT05433675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Macitentan
Description: Macitentan dispersible and film-coated tablets will be administered orally as per assigned treatment sequence.
Study NCT05091476 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OPTiC System
Description: OPTiC System procedure
Study NCT04665609 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib and TQB2450 solution
Description: Anlotinib is a novel multitarget tyrosine kinase inhibitor, inhibiting tumour angiogenesis and proliferative signalling. TQB2450 solution is a new novel of PD-L1 inhibitor made by Crown Bioscience and CHIATAI TIANQING(CTTQ PHARMA).
Study NCT04665609 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TQB2450 solution
Description: TQB2450 solution is a new novel of PD-L1 inhibitor made by Crown Bioscience and CHIATAI TIANQING(CTTQ PHARMA).